Skip to content
Screener

Verrica Pharmaceuticals Inc. VRCA Q3 2025 earnings

Reported November 14, 2025 · Before market open

Revenue$14.3MBeat by $9.8M
EPS$0.13Beat by $1.27
Revenue estimate$4.5M
EPS estimate-$1.14

Next report

Nov 13, 2026 (in 2 months)
Revenue estimate$6.4M
EPS estimate-$0.58

FAQ

When did Verrica Pharmaceuticals Inc. report Q3 2025 earnings?
Verrica Pharmaceuticals Inc. (VRCA) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Verrica Pharmaceuticals Inc.'s Q3 2025 revenue and EPS?
Verrica Pharmaceuticals Inc. reported revenue of $14.3M and eps of $0.13 for Q3 2025.
Did Verrica Pharmaceuticals Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $4.5M by $9.8M. EPS beat the consensus estimate of $-1.14 by $1.27.
How did Verrica Pharmaceuticals Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 905.4% from -$1.8M a year earlier.
Where can I find Verrica Pharmaceuticals Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-283078) and the 10-Q periodic report (0001660334-25-000006) directly on SEC EDGAR. The filing index links above go to sec.gov.